Neutrophil extracellular traps in airway diseases: Pathological roles and therapeutic implications

A Jo, DW Kim - International Journal of Molecular Sciences, 2023 - mdpi.com
Neutrophils are important effector cells of the innate immune response that fight pathogens
by phagocytosis and degranulation. Neutrophil extracellular traps (NETs) are released into …

[HTML][HTML] Strength of association between comorbidities and asthma: a meta-analysis

P Rogliani, R Laitano, J Ora, R Beasley… - European Respiratory …, 2023 - Eur Respiratory Soc
Background The strength of association between comorbidities and asthma has never been
ranked in relation to the prevalence of the comorbidity in the nonasthma population. We …

[HTML][HTML] S-allylmercapto-N-acetylcysteine ameliorates pulmonary fibrosis in mice via Nrf2 pathway activation and NF-κB, TGF-β1/Smad2/3 pathway suppression

Q Zhang, W Ye, Y Liu, D Niu, X Zhao, G Li, Y Qu… - Biomedicine & …, 2023 - Elsevier
Pulmonary fibrosis (PF) is a chronic lung disease characterised by alveolar inflammatory
injury, alveolar septal thickening, and eventually fibrosis. Patients with severe Coronavirus …

ROS induced the Rab26 promoter hypermethylation to promote cigarette smoking-induced airway epithelial inflammation of COPD through activation of MAPK …

B He, Y Wu, W Hu, J Hua, Y Han, J Zhang - Free Radical Biology and …, 2023 - Elsevier
Cigarette smoking (CS) exposure-induced airway inflammatory responses drive the
occurrence and development of emphysema and chronic obstructive pulmonary disease …

Conventional, complementary and alternative medicines: mechanistic insights into therapeutic landscape of chronic obstructive pulmonary disease

R Arezina, T Chen, D Wang - International Journal of Chronic …, 2023 - Taylor & Francis
COPD (chronic obstructive pulmonary disease) is a major public health concern associated
with significant morbidity and mortality worldwide. Current therapeutic guidelines for this …

The efficacy of N-acetylcysteine in chronic obstructive pulmonary disease patients: a meta-analysis

C Huang, S Kuo, L Lin, Y Yang - Therapeutic Advances in …, 2023 - journals.sagepub.com
Background: N-acetylcysteine (NAC) may reduce acute exacerbations of chronic obstructive
pulmonary disease through an antioxidant effect. Due to the heterogeneity in studies, the …

[PDF][PDF] Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion.

W Tang, D Zhu, F Wu, JF Xu, JP Yang… - European Review for …, 2023 - europeanreview.org
OBJECTIVE: Evidence for the mucolytic and expectorant efficacy of intravenous (IV) N-
acetylcysteine (NAC) is limited. This study aimed to evaluate in a large, multicenter …

N‐acetyl‐L‐cysteine ameliorates gestational diabetes mellitus by inhibiting oxidative stress

P Wang, H Ma, X Hou, L Song… - … and Applied Biochemistry, 2023 - Wiley Online Library
Gestational diabetes mellitus (GDM) is a common pregnant disorder that needs careful
medical attention. N‐acetyl‐L‐cysteine (NAC) is a well‐recognized antioxidant to treat …

Новая концепция и алгоритм ведения пациентов с хронической обструктивной болезнью легких

СН Авдеев, ИВ Лещенко, ЗР Айсанов - Пульмонология, 2023 - journal.pulmonology.ru
Аннотация В настоящее время хроническая обструктивная болезнь легких (ХОБЛ)
является глобальной проблемой и одной из ведущих причин смерти в мире. При …

Post-stroke infections: Insights from big data using Clinical Data Warehouse (CDW)

M Jung, HY Park, GY Park, JI Lee, Y Kim, YH Kim… - Antibiotics, 2023 - mdpi.com
This study analyzed a digitized database of electronic medical records (EMRs) to identify
risk factors for post-stroke infections. The sample included 41,236 patients hospitalized with …